Written Question·Department of Health and Social Care·UIN HL15508

Prescription Drugs: Cost Effectiveness

Tabled: 12 March 2026
Answered: 23 March 2026

Question

To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 11 March (HL15135), in what circumstances a direction under the statutory instrument coming into force on 24 March would not be made.

Answer

It is important that there is stability in the medicines regulatory and access landscape, and there should be a high bar for making changes to the cost-effectiveness threshold. It is the Government’s intention, therefore, that the power to set the cost-ef...
ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN HL15508) →